Stereotactic radiation can extend survival for latestage cancer patients

Stereotactic radiation can extend survival for late-stage cancer patients

16:06 EST 1 Feb 2019 | Cardiovascular Business

“In this study, for patients with stage-IV disease, we have a treatment paradigm that can result in long-term survival while maintaining overall quality of life,” said senior author of the study, Dwight E. Heron, MD.

More From BioPortfolio on "Stereotactic radiation can extend survival for late-stage cancer patients"